Endoscopic transluminal pancreatic necrosectomy

Current evidence on the safety of endoscopic transluminal pancreatic necrosectomy shows that there are serious but well‑recognised complications. Evidence on efficacy is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit.

Patient selection should be done by a multidisciplinary team experienced in the management of the condition.

Endoscopic transluminal pancreatic necrosectomy should only be done in a specialist centre by a team experienced in the management of complex pancreatic disease.